Aya Ibrahim
Biographic Data
| ID | 8326560 |
|---|---|
| NAME | Aya Ibrahim |
| GIVEN NAMES | Aya |
| FAMILY NAME | Ibrahim |
| SIGNATURE | IBRAHIM A |
| AFFILIATIONS | Trinity College Dublin |
| ORCID | 0000-0003-1408-7322 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon
Background: A national Oral Cholera Vaccine (OCV) Euvichol-Plus® campaign was launched in Lebanon, in response to the first outbreak in three decades, recorded in October 2022. The OCV vaccination campaign was carried out between November 2022 and February 2023. This study aims to cover adverse events reports, received at the Lebanese National Pharmacovigilance Program's (LNPVP) passive surveillance system. Methods: test. A descriptive analysis w…
Point of care detection of Sars-CoV-2 antibodies and neutralisation capacity—lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance p…
Introduction As the COVID-19 pandemic moves towards endemic status, testing strategies are being de-escalated. A rapid and effective point of care test (POCT) assessment of SARS-CoV-2 immune responses can inform clinical decision-making and epidemiological monitoring of the disease. This cross-sectional seroprevalence study of anti-SARS-CoV-2 antibodies in Irish healthcare workers assessed how rapid anti-SARS-CoV-2 antibody testing can be compare…
No prominent works on this page.
Point of care detection of Sars-CoV-2 antibodies and neutralisation capacity—lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance p…
Introduction As the COVID-19 pandemic moves towards endemic status, testing strategies are being de-escalated. A rapid and effective point of care test (POCT) assessment of SARS-CoV-2 immune responses can inform clinical decision-making and epidemiological monitoring of the disease. This cross-sectional seroprevalence study of anti-SARS-CoV-2 antibodies in Irish healthcare workers assessed how rapid anti-SARS-CoV-2 antibody testing can be compare…
Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon
Background: A national Oral Cholera Vaccine (OCV) Euvichol-Plus® campaign was launched in Lebanon, in response to the first outbreak in three decades, recorded in October 2022. The OCV vaccination campaign was carried out between November 2022 and February 2023. This study aims to cover adverse events reports, received at the Lebanese National Pharmacovigilance Program's (LNPVP) passive surveillance system. Methods: test. A descriptive analysis w…
Immunology (2 works) · Medicine (2 works) · Virology (2 works) · Adverse effect (1 work) · Antibody (1 work) · Biology (1 work) · Cholera (1 work) · Cholera vaccine (1 work) · Family medicine (1 work) · Immune system (1 work)